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Abstract
Clostridium botulinum synthesizes a potent neurotoxin (BoNT) which associates with non-toxic proteins (ANTPs) to form
complexes of various sizes. The bont and antp genes are clustered in two operons. In C. botulinum type A, bont/A and antp
genes are expressed during the end of the exponential growth phase and the beginning of the stationary phase under the
control of an alternative sigma factor encoded by botR/A, which is located between the two operons. In the genome of C.
botulinum type A strain Hall, 30 gene pairs predicted to encode two-component systems (TCSs) and 9 orphan regulatory
genes have been identified. Therefore, 34 Hall isogenic antisense strains on predicted regulatory genes (29 TCSs and 5
orphan regulatory genes) have been obtained by a mRNA antisense procedure. Two TCS isogenic antisense strains showed
more rapid growth kinetics and reduced BoNT/A production than the control strain, as well as increased bacterial lysis and
impairment of the bacterial cell wall structure. Three other TCS isogenic antisense strains induced a low level of BoNT/A and
ANTP production. Interestingly, reduced expression of bont/A and antp genes was shown to be independent of botR/A.
These results indicate that BoNT/A synthesis is under the control of a complex network of regulation including directly at
least three TCSs.
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Introduction
Botulinum neurotoxins (BoNTs) are the most potent toxins
known, and seven BoNT toxinotypes (A to G) have been
recognized based upon their antigenic properties. They are
produced by distinct strains of Clostridium botulinum and by atypical
strains of other Clostridium species that display heterogeneous
bacteriological characteristics. BoNTs are synthesized as single
chain proteins (ap. 150 kDa) and exported outside of the bacteria
by an unknown mechanism. Each toxinotype is proteolytically
cleaved into a heavy chain (H, ap. 100 kDa) and light chain (L, ap.
50 kDa), which remain linked by a disulfide bridge. The H chain
recognizes through its C-terminal part (Hc) a specific cell surface
receptor on nerve endings, and then facilitates toxin uptake into
cells by receptor-mediated endocytosis. The L chain (Lc)
translocates into the cytosol of motoneurons where they gain
access to substrate. L chains are zinc dependent proteases which
specifically cleave one of the three soluble N-ethylmaleimide
sensitive factor (NSF) attachment protein receptors (SNARE), thus
blocking evoked acetylcholine release at the skeletal neuromuscu-
lar junction [1,2].
BoNTs and associated non-toxic proteins (ANTPs) form
complexes of various sizes (300 to 900 kDa). ANTPs consist of a
non-toxic non-hemagglutinin component (NTNH), similar in size
to BoNT, hemagglutinin components (HAs) or other non-
hemaggltuinin proteins called OrfX1, OrfX2, OrfX3 or P47 [3–
6]. ANTPs spontaneously associate with BoNT at low pH by non
covalent bonds and form stable complexes that dissociate at high
pH (pH 8 and above) (rev in [4]). ANTPs are involved in BoNT
protection against acidic pH and proteolytic degradation during
passage through the stomach and intestine. In addition, HA33/35
and HA50, which bind to distinct carbohydrate structures, have
been found to facilitate BoNT transport across the intestinal
barrier [7,8]. It has been reported that HAs of type A and type B,
but not type C, bind to the extracellular domain of human
epithelial E-cadherin and increase the paracellular permeability of
the intestinal barrier by a yet unknown mechanism [9].
The bont and antp genes are clustered in close vicinity and
constitute the botulinum locus. According to bont sequence and
botulinum locus gene organization each botulinum type is divided
in subtypes [10]. In C. botulinum subtype A1 strain Hall, bont and
antp genes are organized in two operons. The first operon (ntnh/A-
bont/A), which is located at the 39 end of the botulinum locus,
encompasses the bont gene immediately preceded by the ntnh/A
gene. Both genes are transcribed in the same orientation, and the
organization of this operon is highly conserved in all C. botulinum
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types. The second operon contains the ha genes and differs slightly
between various toxinotypes. In strain Hall, the ha operon contains
successive genes for the 34 kDa (ha34), 17 kDa (ha17), and 70 kDa
(ha70) HAs [11].
The botR/A gene is localized between the two operons in strain
Hall and is transcribed in the same orientation than BoNT/A.
BotR/A has been characterized as an alternative sigma factor of
RNA polymerase, which positively regulates the transcription of
bont and antp genes [12,13]. BotR/A forms with Clostridium tetani
TetR, C. difficile TxeR (or TcdR) and Clostridium perfringens UviA, a
new sub-group of the sigma 70 family of RNA polymerase
involved in controlling clostridial toxin genes [13]. Transcription
of bont and antp genes in strain Hall is highly regulated at the end of
the exponential growth phase and beginning of the stationary
phase [14]. This supposes that a complex regulatory network may
be involved in the control of toxin synthesis in C. botulinum.
Bacteria typically sense environmental changes using a phosphor-
elay system including at least two proteins known as two-
component systems (TCSs). TCSs consist in a sensor histidine
kinase (SHK), which detects a signal and autophosphorylates on a
histidyl residue. The phosphate group is then transferred to a
conserved aspartyl residue of the response regulator (RR) protein
which is typically a DNA-binding protein that regulates target
gene expression [15]. Some TCSs are known to be involved in the
regulation of virulence factors in Gram-negative and Gram-
positive bacteria. Sequencing of C. botulinum genomes has
identified numerous potential regulatory systems, including TCSs.
According to Sebaihai et al. C. botulinum strain Hall genome
contains 28 putative TCSs, 8 orphan histidine kinases, 8 orphan
response regulators, and 15 sigma factors [11]. In this study we
investigated the potential role of 34 regulatory genes in the
regulation of toxin synthesis; isogenic antisense strains were
constructed using a mRNA antisense approach to silence the
response regulator genes.
Results
Analysis of botR/A isogenic antisense strains
Investigation of putative regulatory genes of the toxinogenesis in
C. botulinum Hall was performed with the anti-sense mRNA
methodology developed for the study of botR/A with some
modifications [12]. Partial inhibition of botR/A expression was
obtained by transfection of Hall strain with the plasmid
pMRP306, which contains the 59end of botR/A gene and the
ribosome binding site (RBS) region cloned in opposite direction
downstream of the iota toxin gene promoter in the pAT19 vector
[12]. In contrast, transfection with pMRP309, which harbors the
whole botR/A gene under its own promoter in pAT19 vector,
resulted in an overexpression of botR/A. Strain Hall/pAT19
contains the empty pAT19 vector. Cultures of strains Hall/306,
and Hall/309 strains showed similar growth kinetics in TGY
medium compared to the control strain Hall/pAT19 (Fig. 1A) or
wild type strain Hall (data not shown) indicating that the vector
alone or containing the anti-sense construct did not significantly
modify the main metabolism of C. botulinum Hall. As expected,
BoNT/A detected in the culture supernatant with ELISA, was
drastically repressed in Hall/306 and overproduced in Hall/309 at
24, 30 and 48 h of growth compared to Hall/pAT19 as control
(Fig. 1B). The effects of partial repression or overexpression of
botR/A on ANTP production were checked by quantified western
blotting with anti-NTNH and anti-HA34 antibodies. Partial
inhibition of botR/A induced a significantly lower production of
NTNH and HA34, whereas opposite effects were observed when
botR/A was overexpressed (Fig. 1C–F).
Expression of the target genes was monitored by quantitative
reverse transcriptase PCR (qRT-PCR) with the primers listed in
Table 1; normalization was based on the expression of the house
keeping gene rpoB. As shown in Fig. 2, bont/A, ntnh, and ha34 genes
were significantly repressed in Hall/306, mainly from the mid
exponential growth phase (4–8 h) until the early stationary phase
(18–24 h). Opposite effects were observed when botR/A was
overexpressed. However, the effects of botR/A overexpression on
bont/A, ntnh, and ha34 genes were only significant during the
exponential growth phase (4–12 h). As monitored by qRT-PCR,
botR/A was markedly overexpressed during the exponential growth
phase (4–12 h) of Hall/309 and to a lower extent during the
stationary phase, whereas a decrease in botR/A expression was
observed only within the exponential growth phase of Hall/306
(Fig. 2B).
Construction of TCS isogenic antisense strains
In further analyses we searched the genome of C. botulinum strain
Hall for additional regulatory systems, in particular TCSs. 39
proteins could be considered as RRs: they all possessed the signal
receiver domain Rec (cd09944) and an additional domain, usually
the DNA binding domain HTH_XRE (cl00088) or LytTR
(cl04498). This is in agreement with the recent analysis of
Galperin et al. [16] showing that bacterial signal transduction
proteins retain a conserved protein family profile. Indeed, of the
39 RRs that we have identified in the Hall strain genome, the
majority (26) belongs to the OmpR family (COG0745) consisting
of RRs with a CheY-like receiver domain and a winged-helix
DNA-binding domain, and 4 other RRs were LytR family
members (COG3279). Nine RRs were orphan regulators and 30
RR genes were located next to a gene coding for a SHK, as judged
by the presence of two domains in the respective gene product, a
histidine kinase-like ATPase (HATPase_c, cd00075) and a
histidine kinase A (dimerization/phosphoacceptor) domain
(HisKA, cl00080). Most TCSs of C. botulinum strain Hall have
close homologues in other Clostridia. Besides C. sporogenes, which is
phenotypically related to C. botulinum but non-toxigenic, homologs
TCSs exist in particular in C. carboxidivorans. However, 12 RRs
have low similarity to proteins in other clostridia. Two RRs
(CLC_0632 and CLC_1105) show homology (38 and 37% protein
identity, respectively) to the VirR regulator, which is part of the
Clostridium perfringens TCS VirR-VirS involved in the regulation of
numerous toxins in this bacterium [17–24].
Plasmids able to generate anti-sense mRNA from 34 predicted
regulatory genes were constructed similarly to pMRP306 and
transfected into strain Hall. DNA segments for anti-sense mRNA
production were designed in the RR gene of 25 TCSs, in the SHK
gene in 4 other TCSs, as well as in 5 orphan regulatory genes
(Table 2).
Growth kinetics of Hall isogenic antisense strains in TGY broth
medium supplemented with erythromycin (10 mg/ml) were
monitored by spectrometry at 600 nm over a 24 h period. 32
Hall isogenic antisense strains showed similar growth kinetics
compared to the control strains (Hall/pAT19 and wild type Hall)
(Fig. 3A, 3B and data not shown). However, growth of strain Hall/
1001 was drastically delayed, and to a lesser extent that of Hall/
652, Hall/716 and Hall/723, whereas two other isogenic antisense
strains (Hall/1147 and Hall/1148) grew faster than the control
Hall/pAT19 (Fig. 3B). However, the five isogenic antisense strains
reached a similar OD than the other isogenic antisense strains at
24 h. Cell counts were performed with three representative strains.
Hall/pAT19 and Hall/707 showed similar growth kinetics than
those monitored by OD600 nm measurements, which were
characterized by an exponential growth curve reaching a plateau
Regulation of Botulinum Neurotoxin Synthesis
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e41848
at 8–12 h followed by a slow decrease in viability (Fig. 3C).
However, Hall/1147 exhibited a different pattern characterized
by a growth curve plateau at 8 h, which was slightly lower than
that of Hall/pAT19 and which was followed by a rapid and drastic
decrease in viability (Fig. 3C).
BoNT/A production is reduced in five TCS isogenic
antisense strains
Among the 34 Hall isogenic antisense strains, 5 showed reduced
BoNT/A production in the culture supernatant in comparison to
Hall/pAT19 as tested by ELISA, namely Hall/707, Hall/714,
Hall/1146, Hall/1147 and Hall/1148 (Fig. 3D). The lower levels
of BoNT/A in the culture supernatants of these isogenic antisense
strains were confirmed by the mouse bioassay, indicating reduced
amounts of biologically active toxin (Table 3). A TCS was targeted
in these 5 isogenic antisense strains with decreased BoNT/A
production. In contrast, the 5 orphan regulatory gene isogenic
antisense strains retained the same levels of BoNT/A production
than the control strain Hall/pAT19. The five isogenic antisense
strains produced a significantly lower level of BoNT/A than Hall/
pAT19 and Hall/306 (Fig. 3D). Indeed a 8 to 10 fold decrease of
BoNT/A production was measured in the supernatant of these
five isogenic antisense strains at 12 and 24 h compared to Hall/
306.The strains Hall/1001, Hall/652, Hall/716 and Hall/723
which exhibited a delayed growth kinetic, were also delayed in
toxin production but yielded a similar BoNT/A level at 24 h
compared to Hall/pAT19 (data not shown). These results indicate
that these mutants displayed a delayed BoNT/A synthesis or
impaired secretion, but were not affected in the global toxin
synthesis rate.
Figure 1. Growth kinetics, BoNT/A, NTNH, and HA34 production in Hall botR/A isogenic antisense strains. (A) Growth curves of Hall/
pAT19 (empty vector), Hall/306 (antisense botR/A mRNA), and Hall/309 (botR/A overexpression) were determined by measurement of optical density
at 600 nm (OD600). (B) BoNT/A was assayed in the culture supernatants by ELISA and expressed as OD at 490 nm. Production of NTNH (C) and HA34
(E) were determined in the supernatant of 12 h cultures by Western blotting with specific antibodies and quantification with ImageJ (D, F) (means +/
2 SD; n = 3), *P,0.05 and **P,0.005. Note that western blotting with anti-NTNH antibodies show native (130 kDa) and partially processed NTNH in
its 115 kDa fragment.
doi:10.1371/journal.pone.0041848.g001
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Two TCS isogenic antisense strains, Hall/1147 and Hall/
1148, show an altered bacterial cell wall/surface layer
Two strains out of the five isogenic antisense strains with a
decreased BoNT/A production grew differently compared to
control strains. Cultures of the TCS isogenic antisense strains
Hall/1147 and Hall/1148, were very viscous at the end of the
exponential growth phase, and the OD600 was significantly higher
than the control strain Hall/pAT19 (Fig. 3B). Cell counting
confirmed that Hall/1147 grew rapidly until 8 h similarly to Hall/
pAT19, although growth yield of Hall/1147 was one log level
reduced compared to the control strain. But Hall/1147 viability
decreased rapidly in the stationary growth phase, with over two log
differences at 12 h compared to the control strain (Fig. 3B). Hall/
1148 showed a similar growth profile than Hall/1147 (data not
shown). This growth behavior suggests that Hall/1147 and Hall/
1148 lyse readily and early. Therefore, we analyzed the strains by
transmission electron microscopy during the mid exponential
growth phase (5 h of culture). After high pressure freezing and
freeze substitution, the cell wall of the control cells showed a
layered organization. The outer part had an electron dense
appearance, whereas the inner part next to the plasma membrane
was electron lucent (Fig. 4A). The electron dense outer layer was
less developed or absent in the Hall/1147 and Hall/1148 strains
(Fig. 4B–C). In addition, the cytoplasm of Hall/1148 bacteria was
less homogenous compared to the control cells and showed
apparently empty areas of various sizes and shapes (Fig. 4C). This
indicates that the TCSs, which were partially repressed in Hall/
1147 and Hall/1148, induced pleiotropic effects including the
regulation of bacterial cell wall or cell surface synthesis as well as
toxin synthesis as shown in Fig. 3C.
Three TCSs control botR/A, bont/A and antp expression at
the transcriptional level
Three TCS isogenic antisense strains (Hall/707, Hall/714,
Hall/1146) showed reduced BoNT/A levels during the exponen-
tial and stationary growth phases, similarly to the isogenic
antisense strain repressed in botR/A (i.e. Hall/306) (Fig. 3B) No
increase in culture viscosity and no microscopic alterations of the
bacterial cell wall was observed in these three strains (data not
shown).
In addition, the three isogenic antisense strains Hall/707, Hall/
714, and Hall/1146 showed also a drastic reduction of ANTP
accumulation in the culture supernatant including NTNH and
HA34 (Fig. 5). This further supports the assumption that the three
Figure 2. Kinetics of transcript levels of bont/A, botR/A, ntnh, and ha34 genes in Hall botR/A isogenic antisense strains. Transcript levels
were quantified by qRT-PCR at 4, 6, 8, 10, 12, 18, 24, 30 and 48 h of culture and normalized versus housekeeping rpoB gene in Hall/pAT19 (empty
vector), Hall/306 (antisense botR/A mRNA), and Hall/309 (botR/A overexpression). Data are mean values +/2 SD from 9 independent experiments,
*P,0.05 and **P,0.005.
doi:10.1371/journal.pone.0041848.g002
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isogenic antisense strains were profoundly impaired in BoNT/A
and ANTP synthesis. To confirm that the observed phenotype, i.e.
decreased BoNT/A and ANTP production, did not result from
spontaneous secondary mutations or antisense off-target effects,
isogenic antisense strains were constructed that targeted the
corresponding SHK gene. The isogenic antisense strains Hall/
707K, Hall/714K, and Hall/1146K showed growth kinetics
similar to those of the control strain Hall/pAT19 (Fig. 6A).
BoNT/A production was reduced in the culture supernatants of
the three isogenic antisense strains targeting the SHK gene
compared to the control strain as monitored by ELISA (Fig. 6B).
The decrease in BoNT/A production was lower in the strains
Hall/707K and Hall/714K than in their counterparts Hall/707
and Hall/714 with antisense mRNA targeting the corresponding
RR gene. Therefore, repression of the RR gene of some TCSs
seems more efficient than that of the SHK gene. In contrast, for
the TCS CLC_0661/CLC0663, targeted in the strains Hall/1146
and Hall/1146K, the inhibition of BoNT/A synthesis was
significantly more pronounced when the SHK gene was repressed
(Hall/1146K) compared to the the strain with the repressed RR
gene (Hall/1146). This might indicate that this TCS particularly
senses an environmental factor critical for BoNT/A synthesis in
the applied culture conditions.
To prove whether the repression of TCSs results in a decreased
BoNT/A and ANTP production due to transcriptional repression,
the expression of bont/A and antp genes was monitored by qRT-
PCR. As shown in Fig. 7, the expression of bont/A, ntnh, and ha34
genes was repressed in isogenic antisense strains Hall/707, Hall/
714, and Hall/1146 similarly to that observed in the isogenic
antisense strain repressed in botR/A (Hall/306). However, no
alteration or even a slight increase in botR/A expression was
observed in these isogenic antisense strains (Fig. 7B). In contrast to
Hall/309, BoNT/A and ANTP synthesis (Fig. 3 and 5) was
reduced in these isogenic antisense strains (Fig. 1). This suggests
that the TCSs partially repressed in Hall/707, Hall/714, and
Hall/1146 control the transcription of bont/A and antp genes
independently of botR/A.
The expression of the RR genes CLC_1093, CLC_1094, and
CLC_0661 (partially repressed in strains Hall/707, Hall/714, and
Hall/1146, respectively) was monitored and compared to rpoB
gene expression (Fig. 8). The levels of expression were similar to
that of botR/A (Fig. 2B). The three RR genes were expressed at
similar levels throughout the exponential and early stationary
growth phase concomitantly with bont/A, ntnh and ha34 gene
expression. Subsequently, at the beginning of the stationary phase
(24 h), their expression seemed to diverge. However, the low
differences in expression levels, slightly decreased for CLC_1914,
and slightly increased for CLC_1093 and CLC_0661, were not
statistically significant (Fig. 8).
Discussion
BoNT synthesis in C. botulinum has been found to be a highly
regulated process. Antp and bont genes are clustered in the
botulinum locus and are transcribed as two polycistronic operons
as evidenced by qRT-PCR or Northern blot analysis [25–27]. The
botR gene, which is located in the botulinum locus in C. botulinum A,
B, C, D, F and G plays a critical role in the regulation of BoNT
and ANTP synthesis. Indeed, BotR/A has been demonstrated to
be an alternative sigma factor controlling the transcription of the
two operons of the botulinum locus at the transition phase from
the exponential to the stationary growth phase [13,14]. However,
in C. botulinum type E, the transcription of bont and antp genes is also
regulated during the transition phase, although botR or a
homologous gene has not been identified in the genome of this
C. botulinum type [14]. This strongly supports that botR is not the
only regulatory gene controlling the expression of toxin gene in C.
botulinum. Since at least 39 putative regulatory genes, distributed in
TCS or orphan RR genes, have been identified in the genome of
Table 1. Primers used to amplify internal fragments of the target genes by quantitative reverse transcriptase PCR.
Gene Primer* Séquence (59-39)
Product
length (bp) Tm (6C)
PCR efficiency
(%)
rpoB F TTCCTCCATCGCTATCTCGT 175 57.5uC 105.1
R AAACATGCAACGTCAAGCAG
bont/A F AATGGTTATGGCTCTACTCAATAC 134 52.7uC 99.6
R GCTAATGTTACTGCTGGATCTG
botR/A F TGACAACGAGGAGTTTCAAGA 146 55.1uC 95.6
R TGAAATTGCTCAAATCAACTTTTT
ha34 F AAGTCGTACAACAAGTGGATATG 148 53uC 105.3
R GTTAGAACTCCGTTTGAAAGTATTG
ntnh/A F AATGTTGTAGTAGTTAGAGCTAG 107 45.1uC 96.5
R CTCAAAGATTCGCCATAATATC
CLC_1093 F CTGCAATGGATGGTGAAGAA 912 60.1uC 89.10
R CTTGCCACAAGCTCCCTTAC
CLC_1094 F GATGGATTAATTGCGGTGGA 865 60.5uC 106.40
R TCATCTCATCCTCCTCTTCTCC
CLC_0661 F AGCTAAAGATGCAAAAGATGCT 889 58.7uC 95.30
R CACAATATCGTTACGGGCAGT
PCR efficiencies correspond to the optimized PCR parameters indicated in Materials and Methods (see also Table S1).
F, forward; R, reverse.
doi:10.1371/journal.pone.0041848.t001
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Table 2. Two-component system and orphan response regulator genes in C. botulinum strain Hall, homology with regulatory
genes in other bacterial species, Hall isogenic antisense strains, and primers used for the construction of recombinant plasmids
generating antisense mRNA.
Iosgenic
antisense strains
Gene Bank accession
numbera
family
(RR) Homologs (RR) in other clostridiab Nucleotide sequence (59R39)
Hall/651 RR CLC_1229
(SHK CLC_1230)
LytR C. ljungdahlii CCGCTGCAGGGAAAAAATGTTGTTAGTATTTTTCATG
CCCCATGGTCATTATCCTCACAAATCATTACTC
Hall/652 SHK CLC_0669
(RR CLC_0668)
YcbB
domain
/ CCGCTGCAGAAGCTTGATAAGGAGATGAAAATAATG
GGCCATGGATACCAAAAGATATATTGAAATGATTAAC
Hall/653 SHK CLC_3251
(RR CLC_3250)
LytR / CCGCTGCAGGAGAAATTTATGATATATATACAATTATTAG
CCCCATGGCAGATTTGTTTTTAATAAATTTATTAAAAG
Hall/660 RR CLC_1431
(SHK CLC_1432)
OmpR / CCGCTGCAGCAGGAGTGATATATATGAGTTATAAG
GGCCATGGCTACTAGTGCTTCGTATCC
Hall/661 RR CLC_2236
(SHK CLC_2235)
OmpR C. sp. 7_2_43FAA C. perfringens C.
beijerinckii C. sp. L2-50 C.
cellulovorans C. ljungdahlii
CCGCTGCAGGCGGATAAGAATGGTTAAGAT
GGCCATGGCCCGTTCTACCATTATTTGCTTTTAC
Hall/662 Orphan RR CLC_2624 CheB C. carboxidivorans C. novyi NT
C. ljungdahlii C. kluyveri
CCGCTGCAGGAGTGATTCATTTGAATAAAATTAAAG
GGCCATGGCTGTATCTATTACTTCTAAATCATTTTC
Hall/663 RR CLC_0376
(SHK CLC_ 0377)
OmpR C. carboxidivorans C. difficile CCGCTGCAGCCTATAATGAATAAGGAGAAAATG
GGCCATGGCTATCTTTACATCAAATCCATATTTAG
Hall/664 RR CLC_2386
(SHK CLC_2385)
OmpR C. kluyveri C. acetobutylicum C.
ljungdahlii C. carboxidivorans C. tetani
C. butyricum C. cellulovorans C. sp.
7_2_43FAA C. beijerinckii C. perfringens
CCGCTGCAGGAGGGGTACCATGGCTATGGAA
GGCCATGGCCCATTCAAAGCACAAATACAGTTATAAC
Hall/666 RR CLC_1871
(SHK CLC_1870)
OmpR / CCGCTGCAGAGGTGTTTATATGCAGGAAAA
GGCCATGGCTTCTCTACCATTACTAGCTGTAATAAC
Hall/667 RR CLC_0842
(SHK CLC_0843)
OmpR / CCGCTGCAGGGGGATTTTGTGACAAAAATATTATTAG
GGCCATGGCTCTTTTAACTTCATAATTTTCTTGTT
Hall/673 SHK CLC_0306
(RR CLC_0307)
NarL C. butyricum CCGCTGCAGGTGAGAATATGAGAAAAGCAATGAAGC
GGCCATGGTTTCCAGTCATCCATGAAACAACAAAAG
Hall/706 RR CLC_1640
(SHK CLC_1639)
OmpR C. carboxidivorans C. novyi NT C. tetani
C. bartlettii C. difficile C. papyrosolvens
CCGCTGCAGAAAGGATGGGACAAGTATGATTG
GGCCATGGCCATCTTTAGCTTTAAAAACAGTTATACC
Hall/707 RR CLC_1093
(SHK CLC_1094)
OmpR C. carboxidivorans C. beijerinckii CCGCTGCAGGGAGAGAAGATATGAAGAAACTC
GGCCATGGCCATCCATTGCAGTTATCACTTCATAATC
Hall707k SHK CLC_1094
(RR CLC_1093)
CCGCTGCAGATTTGGAGGAAAAAATTAATG
GGCCATGGATCCTCTTTATACATATCTTC
Hall/708 RR CLC_0423
(SHK CLC_0424)
OmpR C. carboxidivorans C. tetani C.
acetobutylicum C. ljungdahlii C.
sp. 7_2_43FAA C. butyricum C.
cellulovorans C. beijerinckii
CCGCTGCAGGAGATGATTAAGAAATGTCAGCAG
GGCCATGGATGCCTTTAAAGTTATATAACCTTCATTG
Hall/714 RR CLC_1914
(SHK CLC_1913)
OmpR / CCGCTGCAGGAGATGGATTACAATGCCAAAGAG
GGCCATGGCCACCTCCACTAAATATCCACTTTCC
Hall714k SHK CLC_1913
(RR CLC_1914)
CCGCTGCAGTAAGGGGAGTGGGGTATAAAA
GGCCATGGATTTATATCTAATTTAGG
Hall/716 RR CLC_2079
(SHK CLC_2078)
OmpR C. ljungdahlii C. carboxidivorans C.
beijerinckii C. bartlettii C. butyricum
C. perfringens C. sp. 7_2_43FAA
CCGCTGCAGGGAGGTAGAGTAAGTAATGAAAAAAATTC
GGCCATGGCTCTACAGGTGCATTTACTTCGTATCC
Hall/717 RR CLC_1415
(SHK CLC_1414)
NarL C. acetobutylicum C. sp.
7_2_43FAA C. difficile
CCGCTGCAGGGGAAAAATAAAATGAATAAAACTAATA
GGCCATGGCCGGCAAGACCTACAACTTCAATATCATTG
Hall/720 RR CLC_0354
(SHK CLC_0355)
OmpR C. acetobutylicum C. kluyveri CCGCTGCAGGGGTGATAAATATGGGAAGAAAAGTC
GGCCATGGTTACTTCATACCCTTCACGTTGTAGATAC
Hall/722 RR CLC_3521
(SHK CLC_3520)
OmpR C. carboxidivorans C kluyveri C. novyi
NT C. ljungdahlii C. tetani C. sp.
7_2_43FAA C. beijerinckii C. butyricum
C. acetobutylicum C. perfringens C.
cellulovorans C. thermocellum
CCGCTGCAGGAGGATATACCAATGGAAGG
GGCCATGGTGTCGTATCCTGAATTTTCCAAATAC
Hall/723 RR CLC_1024
(SHK CLC_1025)
OmpR C. phytofermentans C. difficile CCGCTGCAGAGGGATTAATATGGATGCAATATCTTT
GGCCATGGCCTTCTTTTTTAAGTACTGTTCTTATTAATC
Hall/724 RR CLC_1088
(SHK CLC_1089)
OmpR C. sp. 7_2_43FAA C. carboxidivorans C.
acetobutylicum C. ljungdahlii C.
beijerinckii C. tetani C. cellulovorans
CCGCTGCAGAAGGTGAAATAAATGAGTAACATTTTAAT
GGCCATGGTAGTGCAATATACTTTATATCCTTCTTTC
Hall/1001 Orphan RR CLC_0632 LytR / CTGCAGAACTAATAAAAGGGAGGACAT
CCATGGCTTTAATAATTTTTATTAGAT
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C. botulinum strain Hall, we have investigated their possible role in
the control of BoNT/A synthesis.
A total of 34 Hall isogenic antisense strains have been generated
with the antisense mRNA method targeting 29 regulatory genes
predicted to be part of TCSs and 5 putative orphan RR genes.
Among the 34 Hall isogenic antisense strains, 31 retained similar
growth kinetics compared to the control strain, whereas 2 strains
showed a more rapid growth and one isogenic antisense strain had
a significantly delayed growth (Fig. 3B). BoNT/A was detected in
a delayed manner in the culture supernatant of the isogenic
antisense strain with a delayed growth kinetic (Hall/1001), but
reached a similar OD than the control strain at 24 h, indicating
that the repressed corresponding orphan RR (CLC_0632) is
involved in global metabolism but does not directly control toxin
synthesis. Interestingly, CLC_0632 shares sequence similarity with
VirR (38% protein identity), which regulates the production of
toxins in C. perfringens including prefringolysin, alpha-toxin and
collagenase [17,18,28]. VirR belongs to a complex regulatory
network controlling more than 147 genes such as genes for
catalytic enzymes, transporters and energy metabolism and thus
controlling multiple cellular functions [19,20]. CLC_0632 does
not have closer homologs (protein identity .60%) in other
clostridia (Table 2). CLC_1105 also shows similarity to VirR (37%
on protein level). However, Hall/1002 targeting CLC_1105
showed no alteration in growth kinetics and toxin production.
The VirR homologs in C. botulinum Hall probably regulate basic
functions but not specifically BoNT production.
The two isogenic antisense strains with a more rapid growth
(Hall/1147 and Hall/1148) showed drastic changes in the
bacterial cell wall or surface structure, which is probably the
reason for the observed cell lysis. Reduced toxin levels were
measured in the lyzed culture supernatant of both isogenic
antisense strains reflecting lower BoNT synthesis rather than an
impaired secretion. The corresponding RRs (CLC_0411 and
CLC_3293), members of the OmpR family (Table 2), are
probably part of regulatory cascades, which control multiple
functions including bacterial surface polysaccharide synthesis and/
or assembly and indirectly BoNT production. Besides the
HATPase_c and the HisKA domains, the SHK CLC_0411
possesses a partial VicK domain (COG5002). Interestingly, VicK
of Streptococcus mutans has been identified as a TCS sensor involved
in the regulation of several virulence-associated genes affecting
synthesis and adhesion to polysaccharides [30]. SHK CLC_3293
shows similarity to the BaeS family (COG0642) of sensors.
Interestingly, the BaeS sensor in E. coli is involved in envelope
stress response [31]. Taken together, it can be hypothesized that
CLC_0410/CLC_0411 and CLC_3294/CLC_3293 are TCSs
involved in regulating cell surface properties, e.g. surface
polysaccharide synthesis and integrity.
Table 2. Cont.
Iosgenic
antisense strains
Gene Bank accession
numbera
family
(RR) Homologs (RR) in other clostridiab Nucleotide sequence (59R39)
Hall/1002 RR CLC_1105 (SHK
CLC_1104)
LytR C. carboxidivorans C. ljungdahlii CTGCAGTACTTACTTTGGAGGTGATTC
CCATGGTTTTTTAATCGTAAAGCTTC
Hall/1003 RR CLC_0665 (SHK
CLC_0666)
OmpR C. sp. 7_2_43FAA C. beijerinckii
C. difficile C. bartlettii
CTGCAGATATAATTGGAGGAAAATATG
CCATGGTTAAACACATTATACCCCTCA
Hall/1004 RR CLC_0331 (SHK
CLC_0232)
OmpR C. tetani C. acetobutylicum C.
carboxidivorans C. ljungdahlii
CTGCAGTATTTAGAGGAGATTTTTCTA
CCATGGTATACAAAATTATCACAACC
Hall/1140 RR CLC_0323 (SHK
CLC_0324)
OmpR / CCGCTGCAGGTACCTATATGGAGGTATAATTTTATG
GGCCATGGCCTCATTTTCTAAATACAATTTTATAAC
Hall/1141 Orphan RR CLC_0958 OmpR C. cellulovorans C. beijerinckii C.
sp. M62/1 C. symbiosum
CCGCTGCAGAACCTATTAAAAAGGAGGTCTAGATAATG
GGCCATGGCCATTTTTATTAAGTACTGTAC
Hall/1142 RR CLC_2212 (SHK
CLC_2211)
OmpR / CCGCTGCAGATATAAGGTGATATTATGGAAAGG
GGCCATGGCGTATCCTTCTTTTATCAAGG
Hall/1143 Orphan RR CLC_0577 WspR / CCGCTGCAGTTAAATATGAGAGTGATAAGCGTGC
GGCCATGGTTTATGTCTTTTTCCTCTAAAAGATCo
Hall/1144 Orphan RR CLC_0580 Pas_4 and
Hpt
domains
/ CGCTGCAGTAGGGAAGGATAAAATTTATGGTAAAG
GGCCATGGCTTTATCCAAAATGAATATGGAAACG
Hall/1145 SHK CLC_1867 (RR
CLC_1866)
OmpR C. beijerinckii C. bartlettii C.
butyricum C. novyi C. tetani
CCGCTGCAGATGGGGGGGAATTAGTTTGCG
GGCCATGGGCTTTCTATACTTCTTAAATATATTTC
Hall/1146 RR CLC_0661 (SHK
CLC_0663)
OmpR C. tetani C. carboxidivorans C.
sp. 7_2_43FAA
CCGCTGCAGAAGCAATAGGAGGAATTTATAATGG
GGCCATGGATCCATCCGCTCTTAGAGCAG
Hall1146k SHK CLC_0663 (RR
CLC_0661)
CCGCTGCAGAGGAATTCAGAAGCATAAC
GGCCATGGTAACT-
ATAAATGTTCC
Hall/1147 RR CLC_0410 (SHK
CLC_0411)
OmpR C. perfringens C. sp. 7_2_43FAA C.
ljungdahlii
CCGCTGCAGTGAGGTGAAGCCATGG
GGCCATGGCTGCTTCTATTACATCAAAATTGTTCATC
Hall/1148 RR CLC_3294 (SHK
CLC_3293)
OmpR / CCGCTGCAGAGGGGGAGTGCTAATTGAG
GGCCATGGACATCATATCCTTCTTTAAT
aIn bold the accession number of the gene which has been targeted in the isogenic antisense strains and in bracket the associated gene of the corresponding TCS.
bProtein identity .60% (C. sporogenes is omitted due to its high similarity to C. botulinum).
doi:10.1371/journal.pone.0041848.t002
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Interestingly, a quorum sensing system related to that of
Staphylococcus aureus and consisting of two agr loci has been
identified in the group I of C. botulinum strains, which controls
both sporulation and BoNT production. Each agr locus seems to
have a specific function, agr-1 regulating sporulation and agr-2
regulating BoNT synthesis [29]. We have also identified homol-
ogous genes to agrA and agrC from S. aureus in the Hall genome.
The isogenic antisense strain Hall/651 targeting the agrA homolog
was not impaired in BoNT production. Thus, the quorum sensing-
dependent regulation pathway and its effects on the control of
toxin production in C. botulinum remain to be defined.
We showed that three TCSs, CLC_1093/CLC_1094,
CLC_1914/CLC_1913 and CLC_0661/CLC_0663 (were in-
volved in the regulation of e BoNT/A and ANTP production.
BoNT/A, NTNH and HA34 levels in the culture supernatants of
the corresponding isogenic antisense strainsHall/707, Hall/707K,
Hall/714, Hall/714K, Hall/1146, Hall/1146K were repressed
Figure 3. Growth kinetics and BoNT/A production in representative Hall isogenic antisense strains. (A) Hall/707, Hall/714, and Hall/1146
showed a similar growth curve monitored at OD600 than the Hall/pAT19 strain. (B) Hall/1147 and Hall/1148 grew more rapidly than the control Hall/
pAT19 strain, whereas Hall/1001 displayed a slower growth curve. Hall/652, Hall716, and Hall/723 show a similar kinetics compare to Hall/pAT19. (C)
Monitoring of growth kinetics of Hall/pAT19, Hall/707 and Hall/1147 by bacterial counting on TGY agarose and expressed as unit forming colony
(UFC)/ml. (D) BoNT/A production assayed by ELISA was significantly reduced in the culture supernatants of Hall/707, Hall/714, Hall/1146, Hall/1147,
and Hall/748, versus the control Hall/pAT19 strain. BoNT/A production was significantly reduced in Hall/306 at 24 h culture. Data are mean values +/2
SD from 3 independent experiments, *P,0.05.
doi:10.1371/journal.pone.0041848.g003
Table 3. BoNT/A production tested by mouse bioassay in
12 h culture supernatants of the control strain Hall/pAT19 and
isogenic antisense strains.
Recombinant strains Mouse bioassay (DL100/ml)
Hall/pAT19 2.103
Hall/306 20
Hall/309 2.105
Hall/707 (CLC_1093) ,2
Hall/714 (CLC_1914) ,2
Hall/1146 (CLC_0661) ,2
Hall/1147 (CLC_0410) ,2
Hall/1148 (CLC_3294) ,2
doi:10.1371/journal.pone.0041848.t003
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similarly to that observed in the botR/A isogenic antisense strain
(Hall/306). Expression of bont/A, ntnh, and ha34 genes was reduced
throughout the 24 h growth period, as also observed in Hall/306.
However, botR/A expression was not affected or even slightly
increased in the three Hall isogenic antisense strains. These results
argue that the corresponding TCSs, CLC_1093/CLC_1094,
CLC_1914/CLC_1913 and CLC_0661/CLC_0663, control,
directly or indirectly, the expression of the botulinum locus genes
independently of botR/A. Other regulatory genes, notably from the
AraC family, and genes encoding for transporters are distributed
in the vicinity of these TCSs (Fig. 9). This suggests that the TCSs
could be part of a complex regulatory network in response to
external signals. However, the TCS might interact with other
genes, which are distantly located on the genome. The biological
role of the TCS CLC_0661/CLC_0663 remains to be investigat-
ed. The TCS is homologous to TCSs of the PhoP/PhoR family
involved in, but not restricted to, sensing and reacting to
phosphate starvation. It is homologous to CTC00411/
CTC00412 of C. tetani (65% and 53% protein identity, respec-
tively), and CPE2098/CPE2099 of C. perfringens (50 and 40%
identity, respectively). In the latter organism, the system has been
designated VirI/VirJ, and it has been described as ‘‘a novel two-
component regulatory system involved in the shutdown of
extracellular toxin production in C. perfringens’’, although further
data is not available (EMBL/GenBank/DDBJ databases:
BAA78773.1 and BAA78774.1).
Albeit C. botulinum and C. tetani synthesize related neurotoxins, a
specific regulatory network based on TCSs seems to control BoNT
production in C. botulinum type A. The 5 orphan regulatory genes
tested in strain Hall (Table 2) seem not to be involved in the
regulation of the botulinum locus genes. Interestingly, the 5 TCSs,
which directly or indirectly are involved in the regulation of toxin
synthesis in strain Hall, are conserved in the known genomes of C.
botulinum from group I including the subtypes A2, A3, Ba4, B1 and
Figure 4. Ultrastructural morphology of Hall/pAT19, Hall/1447, and Hall/1148. Bacteria from a 5 h culture in TGY were treated by high
pressure and freeze substitution and then observed by electron microscopy. Hall/pAT19 (A) showed a well delineated wall, whereas in Hall/1147 (B)
and Hall/1138 (C) the bacterial wall is transparent, almost invisible. In addition, Hall/1148 (C) showed numerous transparent inclusions. All scale bars
represent 200 nm.
doi:10.1371/journal.pone.0041848.g004
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F, but not in the genomes of group II strains such as C. botulinum
type E or group IV (C. botulinum C and D). These results suggest
that group I C. botulinum strains might share a regulatory network
distinct from that in the other C. botulinum groups.
This raises the question about the external signals governing the
toxin production via TCS regulation. The environmental factors
controlling toxin gene expression in C. botulinum are still poorly
known. Carbon dioxide has been reported to stimulate toxin gene
expression and toxin formation in non-proteolytic C. botulinum
strains type B and E despite a growth rate reduction [32,33], in
contrast to proteolytic C. botulinum type A, which seems insensitive
to carbon dioxide [34,35]. High temperature did not control the
transcription of bont gene but influences the stability of the toxin in
C. botulinum A [14]. A better understanding of the regulation of
toxin synthesis in C. botulinum would permit the development of
novel strategies to prevent botulism by counteracting the toxin
production in food and/or in the digestive tract.
In summary, BoNT/A and ANTP synthesis in C. botulinum
strain Hall seems to be under the control of a complex regulatory
network. In addition to the alternative sigma factor BotR/A,
which regulates bont/A and antp transcription at the transition
phase between the exponential and stationary growth, we have
found that at least three TCSs also control BoNT/A and ANTP
synthesis at the transcriptional level independently of BotR/A.
Two other TCSs seem to retain various pleiotropic effects
including the control of BoNT/A synthesis as well as the
regulation of bacterial cell wall or cell surface synthesis and/or
assembly and granule accumulation in the cytoplasm. Further
investigations of the regulatory network controlling toxin produc-
tion in C. botulinum would allow the identification of environmental
factors triggering BoNT/A synthesis.
Materials and Methods
Bacterial strains and culture conditions
The recombinant strains are presented in figure 1. pat19 vector
was used for the construction of the recombinant ARNm antisense
strains [12]. Escherichia coli strains were grown in Luria-Bertani (LB)
broth and Clostridium botulinum strains in TGY broth (pH 7,5)
containing trypticase (Trypticase-Glucose Yeast Peptone BBL, BD
Biosciences; 30 g/L), yeast extract (Bacto Yeast Extract, BD
Biosciences; 20 g/L), glucose (5 g/L) and cystein, HCl (0,5 g/L)
under anaerobic conditions (N2/CO2/H2; 90 : 5 : 5, vol/vol. at
Figure 5. NTNH and HA34 production in Hall botR/A and 3 TCS isogenic antisense strains. Production of NTNH (A) and HA34 (B) was
assayed by western blotting in 12 h culture supernatants of Hall/pAT19, Hall/306, Hall/309, Hall/707, Hall714, and Hall/1146. Western blots were
quantified by ImageJ (B and D) with normalization of NTNH and HA34 production in Hall/pAT19 to 1. Data are mean values +/2 SD from 3
independent experiments, *P,0.05 and **P,0.005.
doi:10.1371/journal.pone.0041848.g005
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37uC). When necessary, erythromycin was added to culture media
at 20 mg/ml for C. botulinum and 300 mg/ml for E.coli.
Kinetic experiments of C. botulinum recombinant strains were
performed by incubating 10 ml TGY inoculated with 0.3 to
0.6 ml of an overnight preculture to obtain a starting culture of 0.1
OD600. Bacterial growth was monitored as OD600 every two hours
until 12 h, then at 24 and 48 hours of culture for the control
strains and at 8, 12 and 24 hours for isogenic antisense strains.
Bacterial counting was performed in agarose TGY medium
supplemented with erythromycin (5 mg/ml). Serial ten-fold dilu-
tions of cultures were plated on agarose-TGY (0.1 ml on each
plate, 3 plates for each dilution) and incubated at 37uC in
anaerobic chamber.
Construction of vectors encoding antisens mRNA for the
different two-component systems
A DNA fragment of each TCS gene studied containing the
Ribosome Binding Site (RBS) region was amplified by PCR and
inserted in reverse orientation into pAT19 as already described in
[12].
Botulinum neurotoxin and associated protein assay
At 2, 4, 6, 8, 10, 12, 24 and 48 hours culture, 10 ml of culture
were removed. The cells were harvested at 15000 rpm for
5 minutes, and the supernatants were removed and stored at
220uC. The pellets were stored at 280uC for quantitative RT-
PCR analysis.
The toxin content of the supernatants was assessed using an
enzyme-linked immunosorbent assay (ELISA). Ninety-six-well
microtitre plates (Maxisorp, Nunc Roskilde, Denmark) were
sensibilized with 100 ml of monoclonal anti Hc BoNT/A antibody
Mab G14-3 raised against HcBoNT/A1 as previously described
[36] (5 mg/ml in carbonate buffer 0.05 M pH 9.6) and incubated
at 4uC over night. Plates were washed 3 times with PBS-Tween
(0.1%) (PBST) with an automatic plate washer (Bio-Tek, Washer
120) and saturated with 100 ml of BSA (2% in carbonate buffer)
during 30 min under agitation. Three washes were performed and
100 ml of supernatant were added and dilute by half with PBST.
After 30 minutes of incubation under agitation, three washes were
performed, and 100 ml of polyclonal rabbit antibody raised against
HcBoNT/A1 diluted at 1/1600 in PBST, and incubated for an
hour under agitation. Three new washes were performed and
Figure 6. BoNT/A production in isogenic antisense strains targeting the SHK gene from three TCSs. (A) Growth kinetics of Hall/707K,
Hall/714K, and Hall/1146K were similar to that of the control Hall/pAT19 strain as monitored by OD600 measurement. (B) BoNT/A production assayed
by ELISA was significantly reduced in the culture supernatants of Hall/707K, Hall/714K, and to a higher extent of Hall/1146K. Data are mean values +/
2 SD from 3 independent experiments, *P,0.05 and **P,0.005.
doi:10.1371/journal.pone.0041848.g006
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100 ml of goat peroxydase-linked antibody anti-rabbit Ig (111-035-
006, Jackson Immunoresearch) diluted at 1/5000 in PBST was
added and plate were incubated 1 h under agitation. After the last
three washes, detection of toxin was performed by adding 100 ml
of OPD in citrate buffer (0.05 M, 0.06% H2O2, 1 mg/mL of
ortho-phenylen-diamin, Sigma) and incubated seven minutes.
Optical density was measured at 490 nm with a spectrophotom-
eter microplate reader (Biorad, model 680).
The amounts of associated protein HA34 and NTNH in the
supernatants were assessed using a Western blot assay. Total
proteins of 800 ml of a 12 hours culture supernatant were
precipitated with sulfuric acid (pH 3.5) and harvested 5 minutes
at 15000 rpm. Pellets were resuspended in 200 mL of Laemmli
buffer and 15 ml were loaded on a 10% SDS PAGE. The
antibodies used and the immunoblotting procedure were the same
as previously described [12]. Bound antibodies were detected
using an anti rabbit IgG antibody coupled to alkaline phosphatase,
ECFTM Substrate for Western Blotting supplied by Ge Healthcare
and a Storm fluorescent scanning. Western blots were quantified
using Image J software.
Mouse bioassay
In vivo mouse lethality tests were performed for each isogenic
antisense strains showing a manifest decrease in toxin production
by ELISA compared to the control strain. Ten-fold serial dilution
of 24 h culture supernatants in 50 mM phosphate buffer pH 6.5
containing 1% gelatin (PB-G) were done. 0.5 mL was injected
intraperitoneally (i.p) into Swiss mice weighing 20–22 g (Charles
Figure 7. Kinetics of transcript levels of bont/A, botR/A, ntnh, and ha34 genes in Hall/707, Hall/714, and Hall/1146 versus Hall/pAT19
and Hall/306. Transcript levels were quantified by qRT-PCR and normalized versus rpoB gene. Data are mean values +/2 SD, from 9 independent
experiments where *P,0.05 and **P,0.005.
doi:10.1371/journal.pone.0041848.g007
Figure 8. Kinetics of transcript levels of CLC_1093, CLC_1914,
and CLC_0661 in Hall strain. Transcript levels were quantified by
qRT-PCR and normalized versus rpoB gene. Data are mean values +/2
SD, from 3 independent experiments.
doi:10.1371/journal.pone.0041848.g008
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River). Mice were observed and any deaths recorded every day for
4 days.
Ethics statement
All experiments were performed in accordance with French and
European Community guidelines for laboratory animal handling.
The protocols of experiments were approved by the Pasteur
Institut (Agreement of laboratory animal use nu 75–279).
Total RNA extraction, Reverse Transcription and
Quantitative real-time PCR assay
A phenol-chloroform extraction of total RNA was performed
from pellets of each recombinant strains at 8, 12 and 24 hours,
and at each kinetic point for the Pat19, Hall306 and Hall309
strains. Cells were mechanically broken by shaking with a
FastPrep apparatus (MP Biomedicals) and RNA was extracted
with Trizol reagent, and chloroform-isoamylcalcohol. The ex-
tracted RNAs were precipitated with isopropanol and the pellet
was resuspended in a 10 mM Tris pH = 8, 0.1 mM EDTA buffer.
A DNAse treatment with TURBO DNase (Ambion) was
performed on each extract following the manufacturer’s instruc-
tions. The total RNA quantity was measured using a NanoDrop
ND-100 Spectrophotometer and cDNA were synthesized from
5 mg of total RNA with M-MLV Reverse Tanscriptase kit
(Invitrogen) according to manufacturer’s instructions. Hexamer
oligonucleotide primers (pdN6 5 mg/mL), deoxynucleoside triphos-
phates (dNTP; 10 mM each), and RNase OUTTM Recombinant
Ribonuclease Inhibitor are provided from Roche, Amersham
Biosciences and Invitogen respectively. Each extract was analysed
at least once with Agilent 2100 Biolanalyser with RNA 6000 Nano
Reagents & Supplies (Roche).
Reverse-transcribed cDNA samples (30 ng) were subjected to
PCR amplification in 24 ml ready-to-use iQ SYBR Green
Supermix (Bio- Rad, 2X; 1,25 U iTaq DNA polymerase,
0,4 mM each dNTP, 6 mM MgCl2, 20 nM fluorescein, SYBR
Green I) containing 0,5 mM each primer. The reactions were
cycled in an iQ iCycler apparatus (Bio-Rad) using the following
parameters: Taq polymerase activation at 95uC for 3 minutes then
39 cycles at 95uC for 10 s, 51uC for 30 s for ha34 and botR/A genes
and 65uC for rpoB ntnh and bont/A genes for the annealing and the
extension with fluorescence measurement at the end. A temper-
ature gradient was performed for each primer pair with serial 10-
fold dilutions of Hall chromosomal DNA (1.5 pg to 150 ng) to
determine the optimal annealing temperature giving the maximal
PCR efficiency (supplementary Table 1). Each cDNA sample was
PCR amplified in parallel to serially diluted Hall chromosomal
DNA. cDNA quantity of gene was normalized to the quantity of
cDNA of the rpoB gene. The relative cDNA quantity of each
sample was determined with threshold cycle [DDCT] method
Figure 9. Genetic environment of the TCS genes involved in the regulation of toxin synthesis in strain Hall.
doi:10.1371/journal.pone.0041848.g009
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(Analysis of Relative Gene Expression Data Using Real- Time
Quantitative PCR and the 2DDCT method) [37].
The identity and specificity of PCR products were verified by
high resolution agarose gel electrophoresis and a single PCR
product migrating at the expected size was observed for each
primer pair. In addition, an iQ iCycler melting curve (55uC to
95uC with a heating rate of 0, 5uC per 10 s and continuous
fluorescence measurement) confirmed the presence of a unique
peak for the negative first derivative of the temperature versus
fluorescence plotted against temperature (melt curve) with single
product-specific melting temperatures (Tm).
Transmission electron microscopy
All bacterial strains were pelleted using a tabletop centrifuge
and afterwards resuspended in a small amount of medium. The
concentrated suspension was taken up in a cellulose cappillary
tube (Leica microsystems, Vienna, Austria). The tube was cut into
closed pieces not longer than 2 mm with a modified scalpel [38]
and placed into planchettes of 200 mm depth fill with 1-hexadecen.
Cryo-immobilisation was done using a HPM 010 high-pressure
freezer (BalTec, now Abra Fluid AG, Widnau, Switzerland) and
samples transferred under liquid nitrogen for freeze substitution in
1% osmium tetroxide (Merck, Darmstadt, Germany) containing
0.5% glutaraldehyde (EMS, Hatfield, USA) and 0.2% uranyl
acetate (SPI, West Chester, USA) in acetone containing 2% water
in an AFS (Leica microsystems, Vienna, Austria). Substitution was
performed for 48 hours at 290uC, samples were warmed up
(2uC/hour) to 230uC (8 hours) and then warmed up to 0uC
before removal of the substitution medium and embedding in
EPON. After heat polymerization thin sections were cut with an
Ultracut UCT microtome (Leica Microsystems, Vienna, Austria).
Sections were collected on 200 mesh formvar coated copper grids.
After poststaining with 4% uranyl acetate and Reynold’s lead
citrate, the sections were observed with a Jeol 1010 at 80 kV and
equipped with a KeenView camera (Olympus, Soft imaging
systems, Münster, Germany).
Statistics
Values throughout are expressed as means +/2 standard
deviation (SD). Differences in the different isogenic antisense
strains were assessed using unpaired Student’s t-test where
statistical significance is assumed for *P,0.05 and **P,0.005.
Supporting Information
Table S1 Optimization of quantitative PCR amplification. PCR
efficiencies were calculated from a standard curve performed with
a serial 10-fold dilution of chromosomal Hall DNA and a
temperature gradient ranging from 51 to 68uC for each primer
pair targeting bont/A, ntnh, rpob, botR/A, and ha34 genes. Annealing
temperature of 51uC was used in qRT-PCR for ha34 and botR/A
genes, and 65uC for bont/A, ntnh, and rpob genes. These annealing
temperatures yielded a PCR efficiency close of 100% in the largest
range of DNA detection.
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